Creso Pharma Limited, Australian company focused on cannabis derived therapeutics, requests that its securities to be placed in a trading halt.
The company on Monday said that the trading halt has been requested in relation to a certain development in the company’s European operations.
Furthermore, the trading halt should be until the company’s announcement, expected no later than, 18 January 2017.